Pay in 4 interest-free payments of $7.44 Learn more
Ships within 48 hours · Estimated delivery Nov 7 - Nov 12
The effects of tirzepatide on body weight control have also been confirmed in non-diabetic individuals in the SURMOUNT-1 study, where treatment with tirzepatide 1015 mg was associated with an average weight loss of approximately 20% at 72 weeks, exceeding 25% in one third of the patients
Final Thoughts on GLP-1 Weight Loss Treatment When used appropriately and under the supervision of a healthcare provider, GLP-1 treatments can be an effective tool for achieving significant weight loss and improving overall health
You can reach out to the team at any time for questions about how we can assess gaps and help build a more resilience workforce
Nicar MJ, Hill K, Pak CY
For those using tirzepatide to manage blood sugar or metabolic markers, unexplained worsening of these markers after stable control could indicate potency loss from improper storage
The results, which were presented this week at the European Congress on Obesity in Dublin, are among the first indication that the weight loss induced by the new GLP-1 agonist drugs like Wegovy also brings heart health benefits something scientists expected but do not yet have much comprehensive data to prove
US$ 21.95
US$ 20.22
US$ 29.91
